Acceleron Pharma acceleronpharma.com


Public list: Smart Money VCs (6328) Pharma Startups (4732) Cancer Therapeutics (1137) Rare Diseases (230)

Acceleron Pharma is a biopharmaceutical company committed to discover, develop, manufacture and commercialize protein therapeutics for orphan diseases and cancer. Acceleron utilizes biotherapeutic technologies and capitalizes on the company's internal GMP manufacturing capability to advance its therapeutic programs rapidly and efficiently.

Acceleron Pharma is a biopharmaceutical company committed to discover, develop, manufacture and commercialize protein therapeutics for orphan diseases and cancer. Acceleron utilizes biotherapeutic technologies and capitalizes on the company's interna...Show all

Company (IPO / Went public)

Phone: 617-649-9200

Fax:

128 Sidney Street

Cambridge, 02139
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Acceleron Pharma $220.2M Jan 1, 2016
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Acceleron Pharma Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 14 investors

Competitors

Company Status Description Investors

Threshold Pharmaceuticals

Redwood City, California, United States
MergedThreshold Pharmaceuticals is a biotechnology company focused on the discovery, development and commercialization of small molecule therapeutics based on Metabolic Targeting, an approach that offers broad potential to treat most solid tumors and certain other diseases. By selectively targeting tumor and certain other diseased cells, Threshold's pipeline of drug candidates holds promise to be more effective and less toxic to healthy tissues than conventional drugs. Threshold's initial clinical foc...Show allLogin to see details

Tranzyme Pharma

Durham, North Carolina, United States
IPO / Went publicTranzyme is a biopharmaceutical company developing small molecule therapeutics for the treatment of gastrointestinal and metabolic disorders.Login to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Follistatin-related fusion proteins Mar 25, 2016 May 22, 2018 Patent
Isolated nucleotide sequences encoding gdf traps Jul 27, 2016 Apr 03, 2018 Patent
Endoglin polypeptides and uses thereof Apr 19, 2012 Apr 03, 2018 Patent
Follistatin fusion proteins and uses thereof Feb 13, 2015 Mar 20, 2018 Patent
Bmp-alk3 antagonists and uses for promoting bone growth Feb 02, 2015 Mar 13, 2018 Patent
See all 129 patents